Volume 64, Issue 1, Pages (July 2003)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 62, Issue 3, Pages (September 2002)

Beta blockers in the management of chronic kidney disease

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Volume 66, Issue 4, Pages (October 2004)

Naïve and central memory T-cell lymphopenia in end-stage renal disease

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Volume 86, Issue 6, Pages (December 2014)

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Volume 62, Issue 3, Pages (September 2002)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 93, Issue 5, Pages (May 2018)

Burden of chronic kidney disease: North Africa

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Volume 63, Issue 3, Pages (March 2003)

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 72, Issue 9, Pages (November 2007)

Comorbidity and confounding in end-stage renal disease

Volume 63, Issue 2, Pages (February 2003)

Survival advantage in Asian American end-stage renal disease patients1

Volume 70, Issue 11, Pages (December 2006)

Fernando Valderrábano, Francisco Gómez-Campderá, Elizabeth H.P. Jones

Volume 65, Issue 2, Pages (February 2004)

The analysis of survival data: the Kaplan–Meier method

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Immunologic function and survival in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV Kevin C Abbott, MD,

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Racial disparities in access to transplantation: a tough nut to crack

Atrial fibrillation in end-stage renal disease: an emerging problem

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 67, Issue 5, Pages (May 2005)

Unilateral renal cystic disease

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Volume 54, Issue 2, Pages (August 1998)

Stephen P. McDonald, Graeme R. Russ Kidney International

Long-term survival in renal transplant recipients with graft function

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial

Unraveling the racial disparities associated with kidney disease1

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Clinical benefits of slowing the progression of renal failure

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Treatment of the primary hyperoxalurias: A new chapter

Is complement a target for therapy in renal disease?

Volume 75, Issue 7, Pages (April 2009)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Familial phenotype differences in PKD11

Kevin C. Abbott, Robert J. Oglesby, Lawrence Y. Agodoa

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 64, Issue 1, Pages 247-253 (July 2003) Renal cell carcinoma as a cause of end-stage renal disease in the United States: Patient characteristics and survival Kevin P. Stiles, Michael J. Moffatt, Lawrence Y. Agodoa, S. John Swanson, Kevin C. Abbott Kidney International Volume 64, Issue 1, Pages 247-253 (July 2003) DOI: 10.1046/j.1523-1755.2003.00060.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Time, in months, of nephrectomy in relation to date of first end-stage renal disease (ESRD) session in all ESRD patients with renal cell carcinoma (RCC) who initiated ESRD between April 1, 1995, and December 31, 1999, and underwent nephrectomy prior to December 31, 1999, who were eligible for Medicare at the time of first ESRD service. Percentage of patients aged 65 or older is 88%. N = 372. Kidney International 2003 64, 247-253DOI: (10.1046/j.1523-1755.2003.00060.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Time, in months, of nephrectomy in relation to date of first end-stage renal disease (ESRD) session for all patients with renal cell carcinoma (RCC)-initiated ESRD between April 1, 1995, and December 31, 1999, and underwent nephrectomy prior to December 31, 1999, who were not Medicare eligible at the time of first ESRD service. Percentage of patients aged 65 or older is 79%. N = 31. Kidney International 2003 64, 247-253DOI: (10.1046/j.1523-1755.2003.00060.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Mortality of patients with end-stage renal disease (ESRD) due to renal cell carcinoma (RCC) (N = 1646) vs. nondiabetic ESRD (non-Diab) patients (N = 201,279) who initiated ESRD between April 1, 1995, and December 31, 1999.P < 0.01 by log-rank test. Kidney International 2003 64, 247-253DOI: (10.1046/j.1523-1755.2003.00060.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Mortality of patients with end-stage renal disease (ESRD) due to renal cell carcinoma (RCC) who underwent nephrectomy (unilateral or bilateral) (N = 404) vs. all others (N = 1287) who initiated ESRD between April 1, 1995 and December 31, 1999.P < 0.01 by log-rank test. Kidney International 2003 64, 247-253DOI: (10.1046/j.1523-1755.2003.00060.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Mortality of patients with end-stage renal disease (ESRD) due to renal cell carcinoma (RCC) over the age of 65 (N = 996) who underwent nephrectomy (unilateral or bilateral) (N = 347) vs. all others (N = 649) who initiated ESRD between April 1, 1995, and December 31, 1999.P < 0.01 by log-rank test. Kidney International 2003 64, 247-253DOI: (10.1046/j.1523-1755.2003.00060.x) Copyright © 2003 International Society of Nephrology Terms and Conditions